Skip to content

Insider · CIK 0001879013

Guyer William

officer

Files at CORT (CORCEPT THERAPEUTICS INC). First filing Nov 5, 2024, latest Nov 5, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $490k sold

Signals

This insider’s open-market buys and sells, scored.

ScoreSideCompanyValueSharesHoldings changePrice contextFiled
26Weaksell 210b5-1CORT
CORCEPT THERAPEUTICS INC
$490k10,000-81%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 2, 2024CORT
CORCEPT THERAPEUTICS INC
FTax withholding
Common Stock
-309$57.68$18k5,487Dec 4, 2024
Nov 1, 2024CORT
CORCEPT THERAPEUTICS INC
MOption exercise
Common Stock10b5-1
+6,606$21.65$143k12,402Nov 5, 2024
Nov 1, 2024CORT
CORCEPT THERAPEUTICS INC
SOpen-market sale
Common Stock10b5-1
-6,606$48.97$323k5,796Nov 5, 2024
Nov 4, 2024CORT
CORCEPT THERAPEUTICS INC
MOption exercise
Common Stock10b5-1
+3,394$21.65$73k9,190Nov 5, 2024
Nov 4, 2024CORT
CORCEPT THERAPEUTICS INC
SOpen-market sale
Common Stock10b5-1
-3,394$48.97$166k5,796Nov 5, 2024
Nov 1, 2024CORT
CORCEPT THERAPEUTICS INC
MOption exercise
Stock option (right to buy)derivative10b5-1
-6,606$0.00$0453,394Nov 5, 2024
Nov 4, 2024CORT
CORCEPT THERAPEUTICS INC
MOption exercise
Stock option (right to buy)derivative10b5-1
-3,394$0.00$0450,000Nov 5, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.